Takuma Hayashi - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Takuma Hayashi

Showing results (81-90 of 86) with videos related to

Pageof 9

Sort By:

You have reached the last page of results.This site can display upto 86 results.

Anticancer Research|November 1, 2016

Molecular Pathology and Novel Clinical Therapy for Uterine LeiomyosarcomaTakuma Hayashi, Miki Kawano, Tomoyuki Ichimura, et al.

FEBS Letters|June 5, 2012

Potential role of LMP2 as an anti-oncogenic factor in human uterine leiomyosarcoma: morphological significance of calponin h1Takuma Hayashi, Akiko Horiuchi, Kenji Sano, et al.

North American Journal of Medical Sciences|February 25, 2012

Involvement of proteasome β1i subunit, LMP2, on development of uterin leiomyosarcmaTakuma Hayashi, Akiko Horiuchi, Kenji Sano, et al.

Scientific Reports|February 23, 2012

Potential role of LMP2 as tumor-suppressor defines new targets for uterine leiomyosarcoma therapyTakuma Hayashi, Akiko Horiuchi, Kenji Sano, et al.

Arthritis Research & Therapy|May 29, 2026

Deficiency of Krüppel-like factor 15 activates β-catenin and is involved in the development of osteoarthritis : AuthorAkira Saitoh, Shinya Hayashi, Toshiki Kitamura, et al.

International Journal of Clinical Oncology|November 26, 2025

Real-world multicenter study of immune checkpoint inhibitors in advanced cervical cancer across HPV-associated and HPV-independent subtypesKazuhiro Ko, Mayu Fukuda, Koji Yamanoi, et al.

Pageof 9

Search research articles

Showing results (81-90 of 86) with videos related to

Sort By:

Pageof 9

You have reached the last page of results.This site can display upto 86 results.

Anticancer Research|November 1, 2016

Molecular Pathology and Novel Clinical Therapy for Uterine LeiomyosarcomaTakuma Hayashi, Miki Kawano, Tomoyuki Ichimura, et al.

FEBS Letters|June 5, 2012

Potential role of LMP2 as an anti-oncogenic factor in human uterine leiomyosarcoma: morphological significance of calponin h1Takuma Hayashi, Akiko Horiuchi, Kenji Sano, et al.

North American Journal of Medical Sciences|February 25, 2012

Involvement of proteasome β1i subunit, LMP2, on development of uterin leiomyosarcmaTakuma Hayashi, Akiko Horiuchi, Kenji Sano, et al.

Scientific Reports|February 23, 2012

Potential role of LMP2 as tumor-suppressor defines new targets for uterine leiomyosarcoma therapyTakuma Hayashi, Akiko Horiuchi, Kenji Sano, et al.

Arthritis Research & Therapy|May 29, 2026

Deficiency of Krüppel-like factor 15 activates β-catenin and is involved in the development of osteoarthritis : AuthorAkira Saitoh, Shinya Hayashi, Toshiki Kitamura, et al.

International Journal of Clinical Oncology|November 26, 2025

Real-world multicenter study of immune checkpoint inhibitors in advanced cervical cancer across HPV-associated and HPV-independent subtypesKazuhiro Ko, Mayu Fukuda, Koji Yamanoi, et al.

Pageof 9